Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?

Cellular and Molecular Neurobiology

Volumn 21, Issue 3, 2001, Pages 215-235

  Barzilai, Ari ^a   Melamed, Eldad ^a,b   Shirvan, Anat ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; Dopamine; L DOPA; Oxidative stress; Parkinson's disease; Semaphorins

Indexed keywords

DOPAMINE; IRON; LEVODOPA; NEUROMELANIN; SEMAPHORIN; SEMAPHORIN 3A;

APOPTOSIS; BRAIN PROTECTION; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; HUMAN; IRON METABOLISM; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ANIMALS; APOPTOSIS; DOPAMINE; HUMANS; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 0034844226     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010991020245     Document Type: Review

References (126)

1. A novel class of murine semaphorins with homology to thrombospondin is differentially expressed during early embryogenesis
2. Dopamine neurotoxicity: Inhibition of mitochondrial respiration
3. Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease
4. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implication for Parkinson's disease
5. p53 and Bax activated by 6-hydroxydopamine-induced apoptosis in PC12 cells
6. +-induced mitochodrial dysfunction is potentiated by dopamine
7. Neuronal apoptosis
8. Neuropilin-2, a member of the neuropilin family, is a high affinity receptor for the semaphorins sema E and sema IV but not sema III
9. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons
10. Parkinson's disease: A new link between monoamine oxidase and mitochondrial electron flow
11. In vitro induction of apoptosis of differentiation by dopamine in an immortalized olfactory neuronal cell line
12. Selective protection by hsp70 against cytotoxic drug- but not Fas-induced T-cell apoptosis
13. The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53
14. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis via activation of Ref-1 and NF-κB
15. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the Ras-Phosphoinositide 3 kinase and Jun N-terminal kinase pathways
16. Neuronal pigments: Spectroscopic characterization of human brain melanin
17. Prospective for new restorative and neuroprotective treatments in Parkinson's disease
18. Studies in Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed tissues
19. Secreted chick semaphorins bind recombinant neuropilin with similar affinities but bind different subsets of neurons in situ
20. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection
21. +
22. Function in protein folding of TriC, a cytosolic ring complex containing TCP-1 and structurally related subunits
23. Semaphorin III can induce death in sensory neurons
24. A cytoplasmic chaperonin that catalyzed β-actin folding
25. Brain iron and other trace metals in neurodegenerative diseases
26. 1-Trechloromethyl-1,2,3,4-tetrahydro-b-carboline (TaClo) increases extracellular serotonin and stimulates hydroxyl radical production
27. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrastriatal projections and differential neuron susceptibility in Parkinson's disease
28. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine
29. Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine
30. The likeness of being: Phylogenetically conserved molecular mechanism of growth cone guidance
31. Mechanisms and molecules that control growth cone guidance
32. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33
33. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
34. Neurofibrillary tangles-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518 and Ser-522
35. Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules
36. Reactive oxygen species and the central nervous system
37. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution
38. Intrastriatal injection of dopamine results in DNA and apoptosis in rats
39. Neuropilin is a receptor for the axonal chemorepellent semaphorin III
40. The induction of multiple cell cycle events precede target-related neuronal death
41. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: An X ray microanalysis
42. Melanized dopamine neurons are differentially susceptible to degeneration in Parkinson's disease
43. Distribution of semaphorin IV in adult human brain
44. Enhanced oxidative stress and altered antioxidants in brains of bcl2-deficient mice
45. Protein folding in the cells: Function of two families of molecular chaperone HSP60 and TF-55-TCP-1
46. Mechanisms of DA-induced cell death in cultured rat forebrain neurons: Interactions with and differences from glutamate-induced cell death
47. Nuclear translocation of NF-kappa B is increased in dopaminergic neurons of patients with Parkinson disease
48. Neurotransmitters, KCl and antioxidants rescue striatal neurons from apoptotic cell death in culture
49. Oxidative stress and the pathogenesis of Parkinson's disease
50. Levodopa neurotoxicity: Experimental studies versus clinical relevance
51. Quantitation of fluorescence of biogenic monoamines
52. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
53. Relationship between radical intensity and cytotoxic activity of dopamine-related compounds
54. Iron as catalyst of oxidative stress in the pathogenesis of Parkinson's disease?
55. Protective effects of the antiparkinosian drug talipexole and pramipexole against 1-methyl-4-phenylpyridium-induced apoptotic death in human neurobastoma SH-SY5Y cells
56. The semaphoring genes encode a family of transmembrane and secreted grow guidance molecules
57. Growth cones and the cues that repel them
58. Neuropilin is a semaphorin III receptor
59. A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members
60. Cyclin D1 is an essential mediator of apoptotic neuronal cell death
61. Regulation of p53 in response to DNA damage
62. Peroxynitrite- and nitrite-induced oxidation of dopamine: Implication for nitric oxide in dopaminergic cell loss
63. On the occurrence of abnormal deposits of iron in the brain in Parkinson's disease with special references to its location
64. Formation of DNA adducts and oxidative base damage by copper mediated oxidation of dopamine and 6-hydroxydopamine
65. The nerve growth factor-35 years later
66. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydorxy-2H-1,4-benzothiazines-3-carboxylic acid (DHBT-1): A putative nigral endotoxin of relevance to Parkinson's disease
67. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydorxy-2H-1,4-benzothiazines-3-carboxylic acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: Potential relevance to the pathogenesis of Parkinson's disease
68. Katecholsminhaltige neurone in der neuroendokrienen steuerung. Prizip und andwenndung der mikrofkurometric
69. Expression of the dihydropyrImidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the RNA and dysregulated at the protein level
70. Bcl2 overexpression attenuates dopamine-induced apoptosis in an immortalized neuronal cell line by suppressing the production of reactive oxygen species
71. A family of molecules related to collapsin in the embryonic chick nervous system
72. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway
73. Intrastriatal dopamine injection induces apoptosis through oxidative-involved activation of transcription factors AP-1 and NF-κB in rats
74. Possible role of neuromelanin in the pathogenesis of Parkinson's disease
75. Inhibitors of protein synthesis and RNA synthesis prevent neuronal cell death caused by nerve growth factor deprivation
76. Dopamine induces apoptotic cell death of cathecholaminergic cell line derived from the central nervous system
77. Toxicity of dopamine to striatal neuroris in vitro and potentiation of cell death by mitochondrial inhibitor
78. Toxicity of 6-hydroxydopamine and dompamine for domaminergic neurons in culture
79. Enhancing effect of manganese on L-DOPA induced-apoptosis in PC12 cells: Role of oxidative stress
80. DNA damage induced by catechol derivatives
81. +) against mitochondria of mouse brain
82. Mitochondrial dysfunction in Parkinson's disease
83. Inhibition of NADH-linked oxidation in brain mitochondrial by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
84. Methamphetamine-induced dopamine terminals alteration by dopamine D1 and D2 antagonists
85. Dopamine-melanin induces apoptosis in PC12 cells: Possible implications for the etiology of Parkinson's disease
86. Dopamine-induced apoptosis is inhibited in PC12 cells expressing bcl2
87. Prevention of dopamine-induced cell death by thiol antioxidant: Possible implications for treatment for Parkinson's disease
88. Transgenic mice expressing human bcl2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6,tetrahydropyridine neurotoxicity
89. Expression of c-fos, c-jun and c-N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra
90. Activation of nuclear transcription factor kappa B (NF-κB) is essential for dopamine-induced apoptosis in PC12 cells (2000)
91. Bcl-2 and p53: Role in dopamine-induced apoptosis and differentiation
92. The sensory innervation of the mouse spinal cord may be patterned by differential expression of and differential responsiveness to semaphorin
93. Transition metals ferritin, glutathione, and ascorbic acid in parkinsonian brains
94. waf1
95. Biochemical mechanism of action the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)
96. Free radicals scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors
97. Iron and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: Possible insight into iron- and manganese- mediated dopaminergic neurotoxicity
98. Dopamine induces apoptosis in rat striatal neurons: Possible mechanism of D2-dopamine receptor neurons loss during aging
99. Two waves of cyclin B and proliferating cell nuclear antigen (PCNA) expression during dopamine triggered neuronal apoptosis
100. Expression of cell cycle related genes during neuronal apoptosis: Is there a distinct pattern?
101. Semaphorins as mediators of neuronal apoptosis
102. Glutathione protects PC12 cells from ascorbate- and dopamine-induced apoptosis
103. Structure, regulation and function of NF-KB
104. Dopamine induced apoptosis in human neuronal cells: Inhibition by nuclear acids antisense to the dopamine transporter
105. Deficiencies of NADH and succinate dehydrogenase in degenerative diseases and myopathies
106. +) in the neostriatum of the rat
107. Mitochondrial toxin in model of neurodegenerative disease. I: In vitro brain hydoxyl radical production during systemic MPTP treatment of following microdialysis infusion of methylpyridinium or azid ions
108. Increased iron(III) and total iron content in post mortem substantia nigra of parkinsonian brain
109. Dopamine induces neutrophil apoptosis through a dopamine D1 receptor-independent mechanism
110. Intense oxidative DNA damage promoted by L-DOPA and its metabolites. Implications for neurodegenerative disease
111. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: Possible mechanisms of formation involving reactive oxygen species
112. Tyrosinase enhances the covalent modification of DNA by dopamine
113. Dopamine toxicity in neuroblastoma cells: Role of glutathione depletion by L-BSO and apoptosis
114. Induction of apoptosis by dopamine in human oral tumor cell lines
115. The molecular biology of axonal guidance
116. Dopamine and iron induce apoptosis in PC12 cells
117. The cellular response to p53: The decision between life and death
118. Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease
119. Hsp60 accelerates the maturation of caspase 3 by upstream activator protease during apoptosis
120. Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease
121. Monamine-induced apoptotic neuronal cell death
122. Involvement of T-complex protein-δ in dopamine triggered apoptosis in chick embryo sympathetic neurons
123. Dopamine induced apoptosis-like cell death in cultured chick sympathetic neurons - A possible novel pathogenic mechanism in Parkinson's disease
124. Levodopa induces apoptosis in cultured neuronal cells - A possible accelerator of nigrostriatal degeneration in Parkinson's disease
125. The proto-oncogene bcl2 inhibits cellular toxicity of dopamine: Possible implications for Parkinson's disease